Top Markets
Coin of the day
Cellivery Therapeutics, Inc. Cellivery Therapeutics, Inc.

Cellivery Therapeutics, Inc.

268600
Rank in Stocks #19184
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs... Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Share Price
$4.62
Last synced: 2023-03-23
Market Cap
$171.76M
Change (1 day)
-37.16%
Change (1 year)
0.00%
Country
KR
Trade Cellivery Therapeutics, Inc. (268600)

Category

Operating Margin for Cellivery Therapeutics, Inc. (268600)
Operating Margin as of 2026 TTM: 0.00%
According to Cellivery Therapeutics, Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Cellivery Therapeutics, Inc. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.